Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: a systematic review and meta-analysis of individual patient data from 16 randomized controlled trials.
暂无分享,去创建一个
Jayne Tierney | Richard J Stephens | Rodrigo Arriagada | Julian P. T. Higgins | Robert L. Souhami | Anne Auperin | L. Stewart | C. Gridelli | S. Burdett | R. Souhami | R. Arriagada | J. Pignon | R. Stephens | J. Higgins | Douglas B. Johnson | T. Chevalier | A. Aupérin | J. Tierney | C. Péchoux | Lesley A. Stewart | M. Parmar | Jean Pierre Pignon | S Burdett | T. Le Chevalier | C. Le Pechoux | J. van Meerbeeck | M. K. B. Parmar | Nsclc Meta-Anal Collaborat Grp | J. V. Meerbeeck | Sarah Burdett | Y. Cormier | Stephen G. Spiro | Stein Kaasa | Patricia A. Ganz | R. Souhami | D. Bell | M. Parmar | G. Cartei | M. H. Cullen | E. Quoix | E. Rapp | Lesley Seymour | Nick Thatcher | D. Tummarello | C. Williams | I. Williamson | N. Thatcher | S. Spiro
[1] A. Rossi,et al. Erlotinib in non-small cell lung cancer treatment: current status and future development. , 2007, The oncologist.
[2] S. Burdett,et al. Surgery and adjuvant chemotherapy (CT) compared to surgery alone in non-small cell lung cancer (NSCLC): A meta-analysis using individual patient data (IPD) from randomized clinical trials (RCT) , 2007 .
[3] F. Shepherd,et al. Adjuvant Chemotherapy for Early-Stage Non-small Cell Lung Cancer. , 2005, Chest.
[4] L. Stewart,et al. Chemotherapy in non-small cell lung cancer: an update of an individual patient data-based meta-analysis. , 2005, The Journal of thoracic and cardiovascular surgery.
[5] J. Ferlay,et al. Global Cancer Statistics, 2002 , 2005, CA: a cancer journal for clinicians.
[6] J. Holland,et al. Single-agent versus combination chemotherapy in advanced non-small-cell lung cancer: the cancer and leukemia group B (study 9730). , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[7] K. Matsuo,et al. Addition of platinum compounds to a new agent in patients with advanced non-small-cell lung cancer: a literature based meta-analysis of randomised trials. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[8] R. Souhami,et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life , 2004, Thorax.
[9] J. Pignon,et al. Benefits of adding a drug to a single-agent or a 2-agent chemotherapy regimen in advanced non-small-cell lung cancer: a meta-analysis. , 2004, JAMA.
[10] D. Altman,et al. Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.
[11] M. Ranson,et al. Randomized trial of paclitaxel plus supportive care versus supportive care for patients with advanced non-small-cell lung cancer. , 2000, Journal of the National Cancer Institute.
[12] R. Stephens,et al. Gemcitabine plus best supportive care (BSC) vs BSC in inoperable non-small cell lung cancer – a randomized trial with quality of life as the primary outcome , 2000, British Journal of Cancer.
[13] K. Roszkowski,et al. A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC). , 2000, Lung cancer.
[14] Taylor Murray,et al. Cancer statistics, 2000 , 2000, CA: a cancer journal for clinicians.
[15] R. Souhami,et al. Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Thongprasert,et al. Relationship between quality of life and clinical outcomes in advanced non-small cell lung cancer: best supportive care (BSC) versus BSC plus chemotherapy. , 1999, Lung cancer.
[17] M. Parmar,et al. Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints. , 1998, Statistics in medicine.
[18] K. Dickersin,et al. Single agent versus combination chemotherapy in patients with advanced nonsmall cell lung carcinoma , 1998, Cancer.
[19] J. Hainsworth. Chemotherapy in the treatment of non-small cell lung cancer. , 1997, American family physician.
[20] M. Parmar,et al. Chemotherapy in non-small cell lung cancer , 1996, BMJ.
[21] David Machin,et al. Survival Analysis: A Practical Approach , 1995 .
[22] O. Brodin,et al. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials , 1995 .
[23] M. Clarke,et al. Identifying relevant studies for systematic reviews , 1995, BMJ.
[24] K. Dickersin,et al. Systematic Reviews: Identifying relevant studies for systematic reviews , 1994 .
[25] G Cartei,et al. Cisplatin-cyclophosphamide-mitomycin combination chemotherapy with supportive care versus supportive care alone for treatment of metastatic non-small-cell lung cancer. , 1993, Journal of the National Cancer Institute.
[26] F. Guidi,et al. A randomized trial of alternating chemotherapy versus best supportive care in advanced non-small-cell lung cancer. , 1991, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] R. Hatlevoll,et al. Symptomatic treatment versus combination chemotherapy for patients with extensive non‐small cell lung cancer , 1991, Cancer.
[28] S. Gasparini,et al. Lonidamine, chemotherapy (cisplatin and etoposide) and chemotherapy plus lonidamine vs the best supportive care in the treatment of advanced non small cell lung cancer (NSCLC). Preliminary results of a randomized study , 1991 .
[29] C. Williams,et al. A randomised trial of cisplatin and vindesine versus supportive care only in advanced non-small cell lung cancer. , 1990, British Journal of Cancer.
[30] Richard K. Reznick,et al. Survival analysis: A practical approach , 1989, Diseases of the colon and rectum.
[31] R. Figlin,et al. Supportive care versus supportive care and combination chemotherapy in metastatic non‐small cell lung cancer. Does chemotherapy make a difference? , 1989, Cancer.
[32] J L Pater,et al. Chemotherapy can prolong survival in patients with advanced non-small-cell lung cancer--report of a Canadian multicenter randomized trial. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[33] R. Comis,et al. Chemotherapy in the treatment of non-small cell lung cancer. , 1986, Cancer investigation.
[34] R. Peto,et al. Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.
[35] G. Anderson,et al. Response rate and toxicity of etoposide (VP-16) in squamous carcinoma of the lung: report from the Lung Cancer Treatment Study Group. , 1985, Seminars in oncology.